Genetic load makes cancer cells more sensitive to common drugs: evidence from Cancer Cell Line Encyclopedia

Scientific Reports
Ana B Pavel, Kirill S Korolev

Abstract

Genetic alterations initiate tumors and enable the evolution of drug resistance. The pro-cancer view of mutations is however incomplete, and several studies show that mutational load can reduce tumor fitness. Given its negative effect, genetic load should make tumors more sensitive to anticancer drugs. Here, we test this hypothesis across all major types of cancer from the Cancer Cell Line Encyclopedia, which provides genetic and expression data of 496 cell lines together with their response to 24 common anticancer drugs. We found that the efficacy of 9 out of 24 drugs showed significant association with genetic load in a pan-cancer analysis. The associations for some tissue-drug combinations were remarkably strong, with genetic load explaining up to 83% of the variance in the drug response. Overall, the role of genetic load depended on both the drug and the tissue type with 10 tissues being particularly vulnerable to genetic load. We also identified changes in gene expression associated with increased genetic load, which included cell-cycle checkpoints, DNA damage and apoptosis. Our results show that genetic load is an important component of tumor fitness and can predict drug sensitivity. Beyond being a biomarker, genetic load...Continue Reading

References

Oct 1, 1978·Theoretical Population Biology·J Haigh
Sep 1, 1993·The Journal of Heredity·M LynchW Gabriel
Dec 4, 1996·Journal of the National Cancer Institute·E Giovannucci, M E Martínez
Sep 7, 2001·Genes & Development·R T Abraham
Nov 26, 2002·Proceedings of the National Academy of Sciences of the United States of America·Martin A NowakChristoph Lengauer
Dec 4, 2002·Proceedings of the National Academy of Sciences of the United States of America·Tomoko Ohta
Mar 21, 2003·Nature·Xiping WeiGeorge M Shaw
Jul 24, 2003·Journal of Theoretical Biology·Natalia L KomarovaMartin A Nowak
Nov 19, 2003·The Journal of Steroid Biochemistry and Molecular Biology·W YueE L Cavalieri
May 15, 2004·International Journal of Radiation Oncology, Biology, Physics·Roy S Herbst
Oct 12, 2004·Biostatistics·Adam B OlshenMichael Wigler
Sep 7, 2005·Genetics·Robert A Beckman, Lawrence A Loeb
Jan 26, 2007·Nature Reviews. Cancer·Robert T Dorsam, J Silvio Gutkind
Mar 10, 2007·Current Pharmaceutical Design·Luigi LaviolaFrancesco Giorgino
May 15, 2007·Oncogene·A S DhillonW Kolch
Aug 3, 2007·The Journal of Clinical Investigation·Hongtao ZhangMark I Greene
Apr 9, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Yihai CaoEva-Maria Hedlund
Jun 24, 2009·Nature Reviews. Genetics·H Allen Orr
Jul 25, 2009·Nature Reviews. Cancer·Erwin F Wagner, Angel R Nebreda
Jun 11, 2010·Chemistry & Biology·Yves PommierChristophe Marchand
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ivana BozicMartin A Nowak
Jan 29, 2011·Cancer Research·Nicolai J BirkbakCharles Swanton
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
May 20, 2011·Nature Reviews. Cancer·Lawrence A Loeb
Nov 10, 2011·PloS One·Moritz GerstungNiko Beerenwinkel
Aug 23, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhigang C WangUrsula A Matulonis
Dec 1, 2012·Trends in Microbiology·Michael J DappLouis M Mansky
Jan 18, 2013·BMC Bioinformatics·Sonja HänzelmannJustin Guinney
Feb 8, 2013·Proceedings of the National Academy of Sciences of the United States of America·Christopher D McFarlandLeonid A Mirny
Mar 30, 2013·Science·Bert VogelsteinKenneth W Kinzler
Jun 5, 2013·Cold Spring Harbor Perspectives in Biology·Artur A Belov, Moosa Mohammadi
Jul 6, 2013·Science·Annapurna PoduriChristopher A Walsh
Nov 29, 2013·Nature·Benjamin Haibe-KainsJohn Quackenbush
Apr 18, 2014·Nature Reviews. Cancer·Kirill S KorolevJeff Gore
Oct 4, 2014·Proceedings of the National Academy of Sciences of the United States of America·Christopher D McFarlandKirill S Korolev
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Jan 27, 2016·BMC Systems Biology·Julia L FleckChristos G Cassandras

❮ Previous
Next ❯

Citations

Jan 17, 2019·Molecular Biology and Evolution·Yuezheng ZhangXuemei Lu
Dec 12, 2018·Bulletin of Mathematical Biology·Cindy Gidoin, Stephan Peischl
Jun 19, 2019·Medicinal Chemistry·Christiaan W van der WesthuyzenChristopher J Parkinson

❮ Previous
Next ❯

Methods Mentioned

BETA
exome sequencing

Software Mentioned

Gene Set Variation Analysis ( GSVA )
R
GSVA

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.